Sign In
Buy MEDP
$450.82
+5.23 (+1.17%)
At Close: Jun 03, 2026
30,565 Shares in Medpace Holdings Inc (NASDAQ:MEDP) Purchased by Boston Trust Walden Corp
09:36am, Friday, 24'th Apr 2020
Boston Trust Walden Corp purchased a new position in shares of Medpace Holdings Inc (NASDAQ:MEDP) in the first quarter, according to the company in its most recent filing with the Securities & Exchang
Revive Therapeutics Announces U.S. FDA Recommendation to Proceed Directly Into A Phase 3 Confirmatory Clinical Trial | INN
07:47pm, Thursday, 23'rd Apr 2020
Revive Therapeutics (CSE:RVV) has received positive feedback from the U.S. FDA in response to the company’s pre-IND meeting that was announced on April 3, 2020.
China's Contract Research Organization (CRO) Market, Forecast to 2024: A $27+ Billion Opportunity Assessment
10:45am, Thursday, 23'rd Apr 2020
The "China Contract Research Organization (CRO) Market (Clinical, Pre-clinical & Discovery): Insights, Trends and Forecast (2020-2024)" report has been added to ResearchAndMarkets.com's offering.
Medpace Holdings Inc (NASDAQ:MEDP) Shares Purchased by Congress Asset Management Co. MA
10:02am, Thursday, 23'rd Apr 2020
Congress Asset Management Co. MA increased its position in shares of Medpace Holdings Inc (NASDAQ:MEDP) by 27.5% during the first quarter, according to the company in its most recent Form 13F filing w
China Contract Research Organization (CRO) Market Insights, 2020-2024: Clinical, Pre-clinical and Discovery
08:23am, Thursday, 23'rd Apr 2020
Dublin, April 23, 2020 -- The "China Contract Research Organization (CRO) Market (Clinical, Pre-clinical & Discovery): Insights, Trends and Forecast (2020-2024)".
Contract Research Organization Services Market Report 2020: Global Developments Amid COVID-19 Outbreak - ResearchAndMarkets.com
06:06pm, Wednesday, 22'nd Apr 2020
The "Contract Research Organization (CRO) Services - Global Market Outlook (2018-2027)" report has been added to ResearchAndMarkets.com's offering.
Medpace (MEDP) Set to Announce Earnings on Tuesday
06:20am, Tuesday, 21'st Apr 2020
Medpace (NASDAQ:MEDP) is scheduled to be posting its quarterly earnings results after the market closes on Tuesday, April 28th. Analysts expect Medpace to post earnings of $0.78 per share for the quar
Wells and BMO cut views on Gilead in premarket analyst action
11:05am, Monday, 20'th Apr 2020
Benitec Biopharma Limited (NASDAQ:BNTC) initiated with Buy rating and $14 (140% upside) price target at Ladenburg Thalmann.AbbVie (NYSE:ABBV) upgraded to Outperform with a $93 (11% upside) price targe
Allred Capital Management LLC Makes New Investment in Medpace Holdings Inc (NASDAQ:MEDP)
08:44am, Monday, 20'th Apr 2020
Allred Capital Management LLC acquired a new stake in shares of Medpace Holdings Inc (NASDAQ:MEDP) in the first quarter, according to the company in its most recent Form 13F filing with the Securities
Patterson Companies (PDCO) Gets a Buy Rating from Credit Suisse
04:36pm, Sunday, 19'th Apr 2020
Credit Suisse analyst Erin Wright maintained a Buy rating on Patterson Companies (PDCO – Research Report) on April 17 and
Envista Holdings (NVST) Receives a Hold from Credit Suisse
04:36pm, Sunday, 19'th Apr 2020
In a report issued on April 17, Erin Wright from Credit Suisse maintained a Hold rating on Envista Holdings (NVST
Credit Suisse Sticks to Its Buy Rating for DENTSPLY SIRONA (XRAY)
04:36pm, Sunday, 19'th Apr 2020
Credit Suisse analyst
Erin Wright
maintained a
Buy
rating on DENTSPLY SIRONA (
XRAY
–
Research Report
) on April 17 and set a price target of
$50.00
. The company’s shares closed last Friday at $4
Medpace Holdings Inc (NASDAQ:MEDP) Short Interest Update
11:14am, Sunday, 19'th Apr 2020
Medpace Holdings Inc (NASDAQ:MEDP) was the target of a large increase in short interest in the month of March. As of March 31st, there was short interest totalling 2,780,000 shares, an increase of 16.
$0.77 EPS Expected for Medpace Holdings Inc (NASDAQ:MEDP) This Quarter
10:00am, Sunday, 19'th Apr 2020
Equities analysts forecast that Medpace Holdings Inc (NASDAQ:MEDP) will post earnings per share (EPS) of $0.77 for the current fiscal quarter, Zacks Investment Research reports. Five analysts have pro
Credit Suisse Believes Chewy (CHWY) Still Has Room to Grow
05:41pm, Friday, 17'th Apr 2020
In a report released today, Erin Wright from Credit Suisse maintained a Buy rating on Chewy (CHWY), with a price target of $46.00. The company's shares
